Celularity Inc.
Celularity Inc. (CELU): 11 pipeline candidates · ~10 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
9.6 months
D/E -3.82 · 0% dilution
Lead: Phase 2
11 candidates
N/A
N/A
A transparent, data-derived signal for Celularity Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$22.3M
Cash
$16.4M
Quarterly Burn
$5.1M
Runway
9.6 mo
Revenue
$4.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (11 candidates)
| Drug | Phase |
|---|---|
| Celularity Bone Void Filler (CBVF) | — |
| Celularity Placental Matrix (CPM) | — |
| Celularity Tendon Wrap (CTW) | — |
| cenplacel-l | Phase 2 |
| CYCART-19 | — |
| CYNK-001 | Phase 1/Phase 2 |
| cynk-001 systemic | Phase 1/Phase 2 |
| CYNK-101 | Phase 1/Phase 2 |
| interfyl | — |
| PDA-001 | Phase 2 |
Showing 10 of 11 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
35
Total value held
$2.6M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,242,210 | $1.7M |
| geode capital management, llc | 191,076 | $254K |
| blackrock, inc. | 127,501 | $170K |
| vanguard fiduciary trust co | 79,874 | $106K |
| state street corp | 57,830 | $77K |
| valmark advisers, inc. | 49,983 | $66K |
| northern trust corp | 44,163 | $59K |
| keynote financial services llc | 29,320 | $39K |
| royal bank of canada | 18,000 | $24K |
| centerstar asset management, llc | 17,850 | $24K |
Showing top 10 of 35 institutional holders of Celularity Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Celularity Inc.'s pipeline?
Celularity Inc. (CELU) has 11 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Celularity Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Celularity Inc. has approximately 9.6 months of cash runway.
What is Celularity Inc.'s market capitalization?
Celularity Inc.'s market capitalization is approximately $22.3M.
Who is the CEO of Celularity Inc.?
Dr. Robert Joseph Hariri M.D., Ph.D. is the chief executive officer of Celularity Inc. (CELU).
Get the full picture on Celularity Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.